Published in Diabetologia on June 13, 2010
PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N Engl J Med (2012) 3.39
Metformin: multi-faceted protection against cancer. Oncotarget (2011) 2.00
Metformin: an old but still the best treatment for type 2 diabetes. Diabetol Metab Syndr (2013) 1.31
Metformin in cancer prevention and therapy. Ann Transl Med (2014) 1.18
TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations. Nat Commun (2015) 1.10
Animal models of GWAS-identified type 2 diabetes genes. J Diabetes Res (2013) 1.01
HbA1C and cancer risk in patients with type 2 diabetes--a nationwide population-based prospective cohort study in Sweden. PLoS One (2012) 0.95
ADCY5 couples glucose to insulin secretion in human islets. Diabetes (2014) 0.95
Pioglitazone: Indian perspective. Indian J Endocrinol Metab (2011) 0.88
Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone. Elife (2016) 0.78
Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. Int J Mol Sci (2017) 0.77
When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow? Curr Pharmacol Rep (2015) 0.77
The double trouble of metabolic diseases: the diabetes-cancer link. Mol Biol Cell (2015) 0.76
Effect of Melatonin Intake on Oxidative Stress Biomarkers in Male Reproductive Organs of Rats under Experimental Diabetes. Oxid Med Cell Longev (2015) 0.76
Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus. Am J Med Sci (2016) 0.76
Metformin reduces serum CA199 levels in type 2 diabetes Chinese patients with time-effect and gender difference. Diabetes Technol Ther (2014) 0.75
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia (2009) 10.95
Does diabetes therapy influence the risk of cancer? Diabetologia (2009) 3.66
Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia (2005) 3.65
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05
Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia (2010) 2.71
Congenital rubella: citation virus or viral cause of type 1 diabetes? Diabetologia (2008) 2.17
Diet, delusion and diabetes. Diabetologia (2009) 1.87
To boldly go--or to go too boldly? The accelerator hypothesis revisited. Diabetologia (2007) 1.79
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia (2006) 1.60
Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives. Diabetologia (2008) 1.25
Declassifying diabetes. Diabetologia (2006) 1.14
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia (2012) 1.11
Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*. Diabet Med (2010) 1.06
Collateral damage: the conundrum of drug safety. Diabetologia (2009) 1.02
The big fat bariatric bandwagon. Diabetologia (2010) 0.97
Nice insulins, pity about the evidence. Diabetologia (2007) 0.97
Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes. Diabetologia (2002) 0.90
The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence. Diabetologia (2003) 0.90
The prenatal environment and type 1 diabetes. Diabetologia (2013) 0.89
How many people inject insulin? UK estimates from 1991 to 2010. Diabetes Obes Metab (2014) 0.85
Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial. Diabet Med (2005) 0.84
Diabetes in the parents of children with Type I diabetes. Diabetologia (2002) 0.84
Three generations of autoimmune diabetes: an extended family study. Diabetologia (2003) 0.82
Type 1 diabetes in the young: the harvest of sorrow goes on. Diabetologia (2005) 0.82
How to survive diabetes. Diabetologia (2009) 0.80
The changing phenotype of the human species (affluent variety). Diabetologia (2004) 0.75
Eczema and Type 1 diabetes. Diabet Med (2002) 0.75
Inhaled insulin: gone with the wind? Diabetologia (2008) 0.75
Who needs the diabetes specialist physician? Diabetologia (2008) 0.75